Travel Vaccines Market : Segmented By Composition (Mono Vaccines and Combination Vaccines); by Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies and Others); by Application (Domestic Travel and Outbound Travel) and Region - Global Analysis of Market Size, Share & Trends for 2019-2020 and Forecasts to 2030

Publisher Name :
Date: 31-May-2022
No. of pages: 156

Product Overview

A bio-based formulation that is developed to protects humans against infectious diseases caused by bacteria and viruses is known as the vaccine. Vaccines, also known as immunizations, take advantage of our immune system's innate capacity to combat infectious diseases. Travel vaccines are the shots that are given to travelers before visiting any area of the world. These vaccines protect travelers from serious illness and prevent the spread of diseases within and between countries. The body reacts to the vaccine by producing antibodies that will protect a person in the future if one is exposed to the disease. Travel vaccine shots, in addition to a passport, are now needed before embarking on international travel. Health organizations strongly advise visitors traveling to developed or endemic countries to get travel vaccinations. Vaccination guidelines differ from person to person, depending on the tourist's gender, age, and medical background.

Market Highlights

Global Travel Vaccines market is expected to project a notable CAGR of 8.92% in 2030.

Global Travel Vaccines market to surpass USD 13.63 billion by 2030 from USD 5.8 billion in 2020 at a CAGR of 8.92% in the coming years, i.e., 2021-30. The market is estimated to grow on account of rising cases of travel-related diseases such as Hepatitis A & E, typhoid, tetanus, cholera, Japanese encephalitis, diphtheria, meningitis, yellow fever across the globe. Also, mounting investments in the development of more effective vaccines is augmenting the growth of the travel vaccines market. Advancements in technology, increasing government funding and research & development activities are other factors that are contributing to the market growth.

Global Travel Vaccines Market: Segments

Hepatitis A segment to grow with the highest CAGR during 2020-30

Global Travel Vaccines market is segmented by Disease into Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies and Others. It is a viral disease that can be transmitted to other person through direct contact with an infectious person or the ingestion of contaminated food and water. Hepatitis A can cause mild to severe illness

Outbound Travel segment to grow with the highest CAGR during 2020-30

Global Travel Vaccines market is divided by Application into Domestic Travel and Outbound Travel. Outbound Travel segment accounted for the largest revenue share in 2020. Outbound travel refers to traveling to another country. Various travel agencies are present that organize outbound tours. Domestic travel means the traveling between two cities within the same country.

Market Dynamics

Drivers

Rising prevalence of travel-related diseases to bolster growth

Increasing occurrence of travel-related diseases is anticipated to boost the market growth. Traveling is often linked to increased health risks, especially when it comes to infectious diseases. As a result of the increasing occurrence of travel-related diseases, more investments will be made in the global Travel Vaccines Market to produce more effective vaccines.

Government regulations for International Travelers

Government authorization bodies such as the Center for Disease Control and Prevention and the National Health Service have made it mandatory to get travel vaccines. This is attributed to recent surge in inbound tourism to developing countries, which face higher health risks from diseases including swine influenza and Ebola hemorrhagic fever and has been a major driver of the travel vaccines market. In addition, over the last few years, international travel activities have risen immensely due to the growing trend of globalization. This in turn has resulted in a significant demand for travel vaccines.

Restraint

Dearth of skilled workforce

Lack of sufficient skilled workforce for the manufacturing of vaccines is expected to impede the market growth. Furthermore, poor healthcare infrastructure and high cost of travel vaccinations may restrain the market in the coming years.

Global Travel Vaccines Market: Key Players

GlaxoSmithKline Pharmaceuticals Limited

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Sanofi Pasteur

Merck & Co., Inc.

Novartis AG

Pfizer Inc.

ALK-Abelló A/S

Bavarian Nordic A/S

Crucell (Subsidiary of Johnson & Johnson)

CSL Limited

AstraZeneca PLC

Altimmune, Inc.

Abbott Laboratories

Hoffmann-La Roche, Inc.

Other Prominent Players

Global Travel Vaccines Market: Regions

Global Travel Vaccines market is segmented based on regional analysis into five major regions. These include North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. Global Travel Vaccines market in North America held the largest market share in the year 2020. North America being led by the USA is the dominant one. Large number of companies in the region are developing effective travel vaccines, including a vaccine against varicella. Asia Pacific is an emerging market for travel vaccine market owing to improved healthcare infrastructure and increasing healthcare expenditure by government.

Global Travel Vaccines Market is further segmented by region into:

North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR - United States and Canada

Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR - Mexico, Argentina, Brazil, and Rest of Latin America

Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR - United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey, and Rest of Europe

Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR - India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia, and Rest of APAC

Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR - North Africa, Israel, GCC, South Africa, and Rest of MENA

Global Travel Vaccines Market report also contains analysis on:

Travel Vaccines Market Segments:

By Composition

Mono Vaccines

Combination Vaccines

By Disease

Hepatitis A

DPT

Yellow Fever

Typhoid

Hepatitis B

Measles and Mumps

Rabies

Others

By Application

Domestic Travel

Outbound Travel

Travel Vaccines Market Dynamics

Travel Vaccines Market Size

Supply & Demand

Current Trends/Issues/Challenges

Competition & Companies Involved in the Market

Value Chain of the Market

Market Drivers and Restraints

Travel Vaccines Market Report Scope and Segmentation

Frequently Asked Questions

How big is the Travel vaccine market?

What is the Travel Vaccines market growth?

Which segment accounted for the largest Travel Vaccines market share?

Who are the key players in the Travel vaccine market?

What are the factors driving the Travel vaccine market?

Travel Vaccines Market : Segmented By Composition (Mono Vaccines and Combination Vaccines); by Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies and Others); by Application (Domestic Travel and Outbound Travel) and Region - Global Analysis of Market Size, Share & Trends for 2019-2020 and Forecasts to 2030

Table of Contents

1. Executive Summary
2. Global Travel Vaccines Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Travel Vaccines Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Travel Vaccines Market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Travel Vaccines Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Latin America: (Brazil, Mexico, Argentina, Rest of Latin America), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Europe: (Germany, UK, France, Italy, Spain, BENELUX, NORDIC, Hungary, Poland, Turkey, Russia, Rest of Europe), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Asia-Pacific: (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia Pacific), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Middle East and Africa: (Israel, GCC, North Africa, South Africa, Rest of Middle East and Africa), By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Composition: Market Share (2020-2030F)
12.2.1. Mono Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Combination Vaccines, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Disease: Market Share (2020-2030F)
12.3.1. Hepatitis A, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. DPT, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Yellow Fever, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Typhoid, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Hepatitis B, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Measles and Mumps, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.7. Rabies, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.8. Others, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Application: Market Share (2020-2030F)
12.4.1. Domestic Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Outbound Travel, By Value (USD Billion) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
Company Profile
1. GlaxoSmithKline Pharmaceuticals Limited
1. Company Overview
2. Company Total Revenue (Financials)
3. Market Potential
4. Global Presence
5. Key Performance Indicators
6. SWOT Analysis
7. Product Launch
2. Sanofi Pasteur
3. Merck & Co., Inc.
4. Novartis AG
5. Pfizer Inc.
6. ALK-Abelló A/S
7. Bavarian Nordic A/S
8. Crucell (Subsidiary of Johnson & Johnson)
9. CSL Limited
10. AstraZeneca PLC
11. Altimmune, Inc.
12. Abbott Laboratories
13. Hoffmann-La Roche, Inc.
14. Other Prominent Players

Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs